Vývoj syndrómu vynechania u novorodenca po dlhodobej liecbe matky metipranololom v tehotenstve
[Development of a withdrawal syndrome in a neonate after long-term therapy of the mother with metipranolol during pregnancy]
Language Slovak Country Czech Republic Media print
Document type Case Reports, English Abstract, Journal Article
PubMed
7903602
- MeSH
- Adult MeSH
- Pregnancy Complications, Cardiovascular drug therapy MeSH
- Humans MeSH
- Metipranolol adverse effects MeSH
- Infant, Newborn MeSH
- Neonatal Abstinence Syndrome etiology MeSH
- Arrhythmias, Cardiac drug therapy MeSH
- Pregnancy MeSH
- Check Tag
- Adult MeSH
- Humans MeSH
- Infant, Newborn MeSH
- Pregnancy MeSH
- Female MeSH
- Publication type
- English Abstract MeSH
- Journal Article MeSH
- Case Reports MeSH
- Names of Substances
- Metipranolol MeSH
The authors describe the withdrawal syndrome of a beta-adrenolytic in neonates manifested above all 10-16 hours after delivery by alternating bradycardia and marked tachycardia independently on the infant's activity. The withdrawal syndromes correlate with the increased heart rate of the mother after delivery. The authors draw attention to the fact that the withdrawal syndrome in the neonate may develop after delivery if the mother used during pregnancy not only addictive drugs affecting the central nervous system but also drugs affecting the cardiovascular system such as the beta-adrenolytic metipranolol.
